Skip to main content
NVDA+0.10%AAPL-0.38%GOOGL+0.29%MSFT+0.09%AMZN+0.20%TSM-0.22%SPCX-0.08%AVGO-0.18%META+0.35%TSLA-0.11%SKHY+0.11%MU+0.19%BRK-B-0.05%LLY-0.04%JPM-0.07%AMD-0.38%WMT-0.03%V-0.20%XOM-0.22%JNJ-0.01%ASMLa+1.97%INTC+0.46%MA-0.07%0700.HK-1.64%ABBV-0.03%1398.HK-0.27%CSCO-0.01%ORCL0.00%CVX-0.05%BAC-0.03%COST0.00%KO-0.11%DELL+0.16%CAT-0.04%LRCX+0.02%0005.HK+1.13%AMAT+0.06%HSBA.L-1.61%PG-0.04%AP2d+5.05%UNH+0.01%3988.HK0.00%GE-0.13%1816.HK-0.24%MS-0.03%HD-0.03%NFLX+0.19%0857.HK-0.73%0939.HK-0.93%ARM-0.27%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPNZD0.00%GBPSGD0.00%GBPZAR0.00%EURSEK0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%GBPCAD0.00%USDPLN0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%USDZAR0.00%NZDJPY0.00%USDHKD0.00%CADCHF0.00%EURDKK0.00%CADJPY0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.02%ETHUSD+0.18%USDTUSD0.00%XRPUSD+0.10%SOLUSD-0.45%TRXUSDT+1.05%ZECUSDT+2.65%DOGEUSD-0.29%XMRUSDT+2.77%LINKUSD+1.16%XLMUSD+0.04%UNIUSD+1.00%BCHUSDT-1.19%LTCUSD+1.18%HBARUSDT+4.41%TONUSD+24.06%SUIUSD+2.58%TAOUSDT+0.42%AAVEUSD-3.02%DOTUSDT+3.34%ICPUSDT+0.84%ONDOUSDT+0.94%ARBUSDT+2.55%WLDUSDT+2.99%JUPUSDT-0.13%ATOMUSDT+1.40%INJUSDT-2.32%STXUSDT+0.76%FETUSDT-0.11%TIAUSDT-0.64%PYTHUSDT+0.39%SEIUSDT+2.10%IMXUSDT-0.98%OPUSDT+3.24%GRTUSDT+7.69%IOTAUSDT+0.02%WIFUSDT-3.69%POLUSDT+1.90%AXSUSDT-1.68%FARTCOINUSDT+3.78%EOSUSDT+2.69%DYDXUSDT-2.82%ORDIUSDT+1.68%GALAUSDT-0.26%NOTUSDT+3.53%RONINUSDT-2.70%NVDA+0.10%AAPL-0.38%GOOGL+0.29%MSFT+0.09%AMZN+0.20%TSM-0.22%SPCX-0.08%AVGO-0.18%META+0.35%TSLA-0.11%SKHY+0.11%MU+0.19%BRK-B-0.05%LLY-0.04%JPM-0.07%AMD-0.38%WMT-0.03%V-0.20%XOM-0.22%JNJ-0.01%ASMLa+1.97%INTC+0.46%MA-0.07%0700.HK-1.64%ABBV-0.03%1398.HK-0.27%CSCO-0.01%ORCL0.00%CVX-0.05%BAC-0.03%COST0.00%KO-0.11%DELL+0.16%CAT-0.04%LRCX+0.02%0005.HK+1.13%AMAT+0.06%HSBA.L-1.61%PG-0.04%AP2d+5.05%UNH+0.01%3988.HK0.00%GE-0.13%1816.HK-0.24%MS-0.03%HD-0.03%NFLX+0.19%0857.HK-0.73%0939.HK-0.93%ARM-0.27%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPNZD0.00%GBPSGD0.00%GBPZAR0.00%EURSEK0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%GBPCAD0.00%USDPLN0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%USDZAR0.00%NZDJPY0.00%USDHKD0.00%CADCHF0.00%EURDKK0.00%CADJPY0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.02%ETHUSD+0.18%USDTUSD0.00%XRPUSD+0.10%SOLUSD-0.45%TRXUSDT+1.05%ZECUSDT+2.65%DOGEUSD-0.29%XMRUSDT+2.77%LINKUSD+1.16%XLMUSD+0.04%UNIUSD+1.00%BCHUSDT-1.19%LTCUSD+1.18%HBARUSDT+4.41%TONUSD+24.06%SUIUSD+2.58%TAOUSDT+0.42%AAVEUSD-3.02%DOTUSDT+3.34%ICPUSDT+0.84%ONDOUSDT+0.94%ARBUSDT+2.55%WLDUSDT+2.99%JUPUSDT-0.13%ATOMUSDT+1.40%INJUSDT-2.32%STXUSDT+0.76%FETUSDT-0.11%TIAUSDT-0.64%PYTHUSDT+0.39%SEIUSDT+2.10%IMXUSDT-0.98%OPUSDT+3.24%GRTUSDT+7.69%IOTAUSDT+0.02%WIFUSDT-3.69%POLUSDT+1.90%AXSUSDT-1.68%FARTCOINUSDT+3.78%EOSUSDT+2.69%DYDXUSDT-2.82%ORDIUSDT+1.68%GALAUSDT-0.26%NOTUSDT+3.53%RONINUSDT-2.70%
NE

NeoGenomics, Inc. (NEO)

NASDAQHealthcare

$19.91
+$0.01 (+0.1%)
Market closed

Last close at September 18, 2026 at 20:00 UTC

Open$19.91
Day Range$19.4 - $20.03
Avg. Volume (3M)1.8M
Market Cap$511.5M
52 Week Range
$7.07$20.03
Next EarningsIn 37 daysOct 27, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$201.6M100%
Gross Profitminus cost of goods$91.8M46%
Net Incomeminus taxes and the rest$2.2M1%

In plain terms: out of every $100 in revenue, NeoGenomics, Inc. keeps $1 as net profit.

Fundamentals & Financials

Revenue (TTM)
$766.2M
Net Income (TTM)
-$51.8M
EPS (TTM)
-$2
ROA (TTM)
-3.84%
Current Ratio
3.6
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+50.0%Q1 2026$0.06
+73.0%Q2 2026$0.01
+49.0%Q3 2026$0.05
Next

Oct 27

in 37 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +49.0%

NeoGenomics beat expectations on revenue in the second fiscal quarter of 2026, reported July 28, 2026, with revenue up 11.2% to about $201.7 million (from roughly $181.3 million a year ago) as its cancer-focused testing and research services business continued to expand across Clinical Services and Pharma Services. On the consensus comparison, revenue of $201.7 million topped the $196.9 million estimate, +2.4%. Gross profit came in at about $91.9 million, translating to a gross margin of roughly 46%, while profitability remained negative at the operating line with operating income of about -$9.8 million and an operating margin of around -5%. Adjusted EPS was $0.05, up from $0.03 a year ago. The company generated operating cash flow of about $20.0 million during the quarter and repurchased roughly $22.7 million of stock. For the next period, consensus calls for EPS of $0.06 on revenue of $205.9 million.

View full earnings history

About NeoGenomics, Inc.

NeoGenomics, Inc. provides cancer-focused diagnostic testing and research services within healthcare, operating in the medical diagnostics and research business. Listed on the NASDAQ as NEO, it generated $727.3 million of revenue in FY2025 through laboratory testing for patient care and services that support drug-development programs.

Name
NeoGenomics, Inc.
CEO
Anthony Zook
Industry
Healthcare
Year Founded
2001
Employees
2,500

Today's Snapshot

AI-generated

NEO ended the day slightly higher at 19.91, in line with a flat sector. Volume was roughly twice its usual level. Simply Wall St. said NeoGenomics shares look expensive relative to its current sales.

Trading Volume

Above 10d avg 1.7M

3.6M

vs S&P 500 Today

Inline with Market

+0.02%

Updated: September 18, 2026 at 20:06 UTC

Technical Indicators

6 Buy0 Neutral2 Sell
NEO, at about 19.91, shows a strong bullish structure with price comfortably above short-, medium- and long-term moving averages and a high ADX of 49.27 indicating a powerful trend. Momentum measures are emphatic — MACD and CCI are positive and momentum is supportive — though RSI and Stochastic are in overbought territory and the upper Bollinger band is being tested, suggesting stretched conditions. ATR shows moderate intraday range while OBV confirms heavy accumulation. Technical takeaway: Strong Buy underpinned by a strong trend, broad moving-average support and heavy volume, but momentum readings are extended.
All signals
  • EMA (5 indicators)$12.82 - $18.66
    Buy
  • RSI (14)73.90
    Sell
  • Stochastic %K (14, 3, 3)89.36
    Sell
  • MACD Level (12, 26)0.87
    Buy

Peers & Related Assets

ARCTArcturus Therapeutics Holdings Inc.
$16.03-5.3%
QTRXQuanterix Corporation
$3.07-1.6%
HUMAHumacyte, Inc.
$0.59+1.8%
ACRSAclaris Therapeutics, Inc.
TKNOAlpha Teknova, Inc.
SGMTSagimet Biosciences Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.